HBSXNBM(SH:600293)2022-10-27 16:00Financial Performance - The company's operating revenue for Q3 2022 was ¥508,086,384.15, a decrease of 35.61% compared to the same period last year[4]. - The net profit attributable to shareholders was -¥109,144,913.57, representing a decline of 147.03% year-on-year[4]. - The net cash flow from operating activities was -¥35,480,157.47, down 124.12% compared to the previous year[4]. - Basic earnings per share were -¥0.09, a decrease of 145.00% from the same period last year[5]. - Total operating revenue for the first three quarters of 2022 was CNY 1,444,917,841.90, a decrease from CNY 2,205,707,944.12 in the same period of 2021, representing a decline of approximately 34.5%[18]. - The net profit for the third quarter of 2022 was a loss of CNY 87,593,654.98, compared to a profit of CNY 142,934,611.02 in the same quarter of 2021, reflecting a significant decline[20]. - The company reported a total comprehensive loss of CNY 87,593,654.98 for the third quarter of 2022, compared to a comprehensive income of CNY 141,231,557.66 in the same quarter of 2021[21]. - The company reported a net loss of ¥46,676,720.13 for the first three quarters of 2022, contrasting with a profit of ¥614,042,885.36 in the same period of 2021[27]. - The company reported a total comprehensive income of -47,099,420.70 RMB for Q3 2022, compared to 559,160,650.17 RMB in Q3 2021, highlighting a substantial loss[28]. Assets and Liabilities - Total assets at the end of the reporting period were ¥3,924,019,683.83, an increase of 4.32% from the end of the previous year[5]. - As of September 30, 2022, the company's total assets amounted to RMB 3,924,019,683.83, an increase from RMB 3,761,655,323.10 at the end of 2021, reflecting a growth of approximately 4.33%[14]. - The total liabilities as of the third quarter of 2022 amounted to CNY 1,877,349,437.57, an increase from CNY 1,627,391,421.86 in the previous year[19]. - The total liabilities as of September 30, 2022, amounted to ¥1,450,539,294.52, slightly up from ¥1,439,538,407.25 at the end of 2021[26]. - The total equity attributable to shareholders of the parent company was CNY 1,898,315,298.14, down from CNY 1,972,385,878.65 in the same period of 2021, indicating a decrease of about 3.8%[19]. - The total equity decreased to ¥1,829,637,960.51 as of September 30, 2022, from ¥1,876,737,381.21 at the end of 2021, indicating a decline of 2.5%[27]. Cash Flow - The net cash flow from operating activities for Q3 2022 was ¥28,363,533.60, a significant decrease from ¥234,224,768.97 in Q3 2021, representing an 87.9% decline[23]. - Cash inflows from operating activities for the first three quarters of 2022 totaled CNY 1,065,038,936.26, down from CNY 1,585,307,590.03 in the same period of 2021, a decrease of approximately 32.7%[22]. - The net cash flow from operating activities was -58,529,093.85 RMB for the first nine months of 2022, compared to a positive cash flow of 149,878,713.91 RMB in the same period of 2021[31]. - The total cash inflow from financing activities in the first nine months of 2022 was 315,550,800.00 RMB, compared to 481,372,750.00 RMB in the same period of 2021, showing a decline of 34.5%[31]. - The company experienced a cash outflow of 180,071,000.00 RMB related to financing activities in the first nine months of 2022, compared to only 2,035,903.52 RMB in the same period of 2021, indicating a significant increase in financing costs[31]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 54,074[10]. - The top shareholder, Shenzhen Qianhai Jiahua Investment Partnership, held 95,438,680 shares, accounting for 8.23% of the total shares[11]. Operational Insights - The decline in operating revenue and net profit was primarily due to a significant drop in product sales prices and a reduction in the scope of consolidation[9]. - The company received government subsidies amounting to ¥1,071,053.33 during the reporting period[7]. - The company has not disclosed any new product developments or market expansion strategies in the provided documents[13]. - There are no significant mergers or acquisitions mentioned in the current report, indicating a focus on internal growth and asset management[13]. Inventory and Expenses - Inventory levels rose to RMB 272,169,145.67, compared to RMB 186,440,237.43, marking an increase of around 45.96%[15]. - Research and development expenses for the first three quarters of 2022 were ¥78,572,035.69, a decrease of 4.0% compared to ¥82,158,772.00 in the same period of 2021[27]. - The company's financial expenses for the third quarter of 2022 were CNY 15,367,963.26, significantly reduced from CNY 73,769,204.77 in the same quarter of 2021, indicating a decrease of about 79.2%[19].